KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Amortizatization of Intangibles (2020 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Amortizatization of Intangibles for 6 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 21.62% year-over-year to $2.3 million, compared with a TTM value of $10.2 million through Dec 2025, down 20.05%, and an annual FY2025 reading of $10.2 million, down 20.05% over the prior year.
  • Amortizatization of Intangibles was $2.3 million for Q4 2025 at Aurinia Pharmaceuticals, down from $2.6 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $3.4 million in Q3 2024 and bottomed at -$290000.0 in Q3 2022.
  • Average Amortizatization of Intangibles over 5 years is $2.0 million, with a median of $2.6 million recorded in 2023.
  • The sharpest move saw Amortizatization of Intangibles plummeted 190.67% in 2021, then soared 1965.0% in 2023.
  • Year by year, Amortizatization of Intangibles stood at $1.2 million in 2021, then skyrocketed by 30.27% to $1.6 million in 2022, then surged by 112.13% to $3.3 million in 2023, then decreased by 9.86% to $3.0 million in 2024, then decreased by 21.62% to $2.3 million in 2025.
  • Business Quant data shows Amortizatization of Intangibles for AUPH at $2.3 million in Q4 2025, $2.6 million in Q3 2025, and $2.6 million in Q2 2025.